Literature DB >> 15306124

Modulation of the Omi/HtrA2 signaling pathway after transient focal cerebral ischemia in mouse brains that overexpress SOD1.

Atsushi Saito1, Takeshi Hayashi, Shuzo Okuno, Tatsuro Nishi, Pak H Chan.   

Abstract

Omi/HtrA2 is a novel protein that contributes to the regulation of mitochondrial apoptosis after a variety of cell death stimuli in vitro and is thought to negatively control the inhibitor-of-apoptosis protein (IAP) family. However, the Omi/HtrA2 pathway remains unknown in apoptotic neuronal cell death in vivo. To examine the role of the Omi/HtrA2 pathway and its relationship to oxidative stress after reperfusion following cerebral ischemia, we used a transient focal cerebral ischemia (tFCI) model in copper/zinc-superoxide dismutase (SOD1) transgenic mice and wild-type mice. We evaluated the link between the Omi/HtrA2 pathway and the caspase cascade reaction after tFCI by administration of a pan-caspase inhibitor, Z-VAD-FMK. We observed the time-dependent expression of Omi/HtrA2 and its binding to X-chromosome-linked IAP (Omi/XIAP) by immunohistochemistry, Western blotting and coimmunoprecipitation. Translocation of Omi/HtrA2 into the cytosolic space was detected during the early period after tFCI and was not affected by Z-VAD-FMK administration, but it was prevented by SOD1 overexpression. Coimmunoprecipitation revealed that Omi/XIAP transiently increased and that it was prevented by SOD1 overexpression. These results suggest that the Omi/HtrA2 pathway may play an important role in the progress of apoptotic neuronal cell death and that overexpression of SOD1 may attenuate this apoptotic cell death by preventing the Omi/HtrA2 cell signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306124     DOI: 10.1016/j.molbrainres.2004.05.012

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  8 in total

1.  Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury.

Authors:  Xiang Yun; Victor D Maximov; Jin Yu; Hong Zhu; Alexey A Vertegel; Mark S Kindy
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-06       Impact factor: 6.200

Review 2.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

Review 3.  Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities.

Authors:  Venkata Prasuja Nakka; Anchal Gusain; Suresh L Mehta; Ram Raghubir
Journal:  Mol Neurobiol       Date:  2007-12-08       Impact factor: 5.590

Review 4.  Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia.

Authors:  Kuniyasu Niizuma; Hideyuki Yoshioka; Hai Chen; Gab Seok Kim; Joo Eun Jung; Masataka Katsu; Nobuya Okami; Pak H Chan
Journal:  Biochim Biophys Acta       Date:  2009-09-12

5.  The role of PARL and HtrA2 in striatal neuronal injury after transient global cerebral ischemia.

Authors:  Hideyuki Yoshioka; Masataka Katsu; Hiroyuki Sakata; Nobuya Okami; Takuma Wakai; Hiroyuki Kinouchi; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

6.  Genetic modulation of striatal volume by loci on Chrs 6 and 17 in BXD recombinant inbred mice.

Authors:  G D Rosen; C J Pung; C B Owens; J Caplow; H Kim; K Mozhui; L Lu; R W Williams
Journal:  Genes Brain Behav       Date:  2009-01-12       Impact factor: 3.449

7.  Oxygen-Dependent Gene Expression in Development and Cancer: Lessons Learned from the Wilms' Tumor Gene, WT1.

Authors:  Holger Scholz; Karin M Kirschner
Journal:  Front Mol Neurosci       Date:  2011-02-24       Impact factor: 5.639

8.  Cardiac Specific Overexpression of Mitochondrial Omi/HtrA2 Induces Myocardial Apoptosis and Cardiac Dysfunction.

Authors:  Ke Wang; Yuexing Yuan; Xin Liu; Wayne Bond Lau; Lin Zuo; Xiaoliang Wang; Lu Ma; Kun Jiao; Jianyu Shang; Wen Wang; Xinliang Ma; Huirong Liu
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.